Xiaohui Zhang
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology · 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China · Peking University People's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xiaohui Zhang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:47 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07586813 · Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsPeking University People's Hospital · recruiting · Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gastrointestinal Neoplasms · principal investigator
- Ph2NCT07586826 · Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsPeking University People's Hospital · recruiting · Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gynecologic Cancers · principal investigator
- N/ANCT07449858 · 18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLCSecond Affiliated Hospital, Zhejiang University, School of Medicine · active not recruiting · Non Small Cell Lung Cancer · principal investigator
- Ph1NCT07315373 · Optimal Dose of Zanubrutinib to Treat Adult Immune ThrombocytopeniaPeking University People's Hospital · not yet recruiting · Immune Thrombocytopenia · principal investigator
- N/ANCT07101770 · A Prediction Model in Pregnant Women With Aplastic AnemiaPeking University People's Hospital · recruiting · Aplastic Anemia, Pregnancy, Prediction Model · principal investigator
- Ph2NCT07057778 · Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITPPeking University People's Hospital · not yet recruiting · Immune Thrombocytopenia (ITP) · principal investigator
- Ph2NCT06577909 · Prednisone Plus IVIg vs. Prednisone for ITP During PregnancyPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2/Ph3NCT06202625 · Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCTPeking University People's Hospital · unknown · Thrombocytopenia, Stem Cell Transplant Complications · principal investigator
- N/ANCT06022445 · Prospective Validation of CARPET Prognostic Model for Septic Shock After Allo-HSCTPeking University People's Hospital · unknown · Stem Cell Transplant Complications · principal investigator
- Ph2NCT05932524 · Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT05852847 · Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT05446831 · Baricitinib for Steroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · ITP, Immune Thrombocytopenia · principal investigator
- Ph3NCT05438875 · The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9Peking University People's Hospital · completed · Purpura, Thrombocytopenic, Idiopathic · principal investigator
- Ph2NCT05369364 · The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT05369377 · Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph3NCT04738981 · Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCTPeking University People's Hospital · completed · Graft Vs Host Disease · principal investigator
- Ph2NCT04618328 · A Study of ATRA in the Treatment of ITPPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph1NCT04518878 · Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)Peking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT04516837 · Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)Peking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT04481282 · The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT04368598 · The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITPPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT04217148 · The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaPeking University People's Hospital · completed · Immune Thrombocytopenia · principal investigator
- Ph2NCT03909763 · Combination of Danazole With Berberine in the Treatment of ITPPeking University People's Hospital · unknown · Corticosteroid-resistant or Relapsed ITP · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:47 UTC. The ranking covers the 200 most relevant of 4059 PubMed records, and a shared surname and initials can bring in a namesake. All 4059 on PubMed
- Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.N Engl J Med · 2025176 citationsRCR 53.9
- 163 citationsRCR 33.1
- Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer.N Engl J Med · 2025124 citationsRCR 28.3
- Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.N Engl J Med · 202595 citationsRCR 17.4
- 53 citationsRCR 15.7
- Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours: The HOPE Randomized Clinical Trial.JAMA · 202550 citationsRCR 14.4
- 46 citationsRCR 23.1
- Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial.Ophthalmology · 202639 citationsRCR 19.6
- 37 citationsRCR 8.0
- 36 citationsRCR 5.8